San Diego-based biotech firm Debut, backed by a $40 million series B funding led by L’Oréal’s venture capital fund, Bold, aims to revolutionize the fragrance industry’s sustainability. Debut’s innovative biotechnology focuses on crafting bio-identical and novel fragrance molecules, facilitating a shift towards bio-based formulas for fragrance brands.
Their technology not only replicates the intricate olfactive profiles of natural ingredients, including rare and complex ones that are challenging to obtain in nature but also preserves the formulas’ integrity. This strategic approach promises to make fragrance production more environmentally friendly while preserving the aromatic essence that consumers cherish.
Add Comment